| Investment Advisory |
|
Investment in China healthcare industry has been a hot topic lately. The exponential growth of Chinese healthcare market has captured the strong interest of global financial institutions. The foreign capital invested in both private and public Chinese healthcare companies has been growing dramatically in the past few years. There has been strong demand for quality investment and business analysis on candidate companies that have the promising prospect of both growth and profitability.
Our consultants for investment advisory service consist of the industrial experts with many years of the experience in the Chinese financial industry and the impressive career achievements. Partnering with professional accounting firms and investment banking firms in China, we are in a good position to offer you reliable investment opinions and help you complete the deal transaction both efficiently and effectively.
The scope of our investment advisory service includes:
Testimonial“The timely advice from CHG’s team helped us quickly identify the investment candidates in China that showed the prospect of tremendous growth in the healthcare industry. Their insightful analysis allowed us to invest these companies at the very attractive price levels. Thanks!”—Eric young, portfolio manager. A U.S. hedge fund company with $3 billion investment capital. |
| < Prev | Next > |
|---|
Service Activities
Industrial News
- China Aoxing Pharmaceutical Company Receives Government Approval for Increased Ownership of its Main
- Reform to target hefty medicine costs
- China to develop traditional medicine vigorously
- Novartis to move Indian R&D operations to China: Financial Times
- India and China competing on pharma potential